284 related articles for article (PubMed ID: 31151454)
21. Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus.
Yen FS; Wang HC; Pan CW; Wei JC; Hsu CC; Hwu CM
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31544207
[TBL] [Abstract][Full Text] [Related]
22. Incidence of stroke, subsequent clinical outcomes and health care resource utilization in people with type 2 diabetes: a real-world database study in France: "INSIST" study.
Mohammedi K; Fauchier L; Quignot N; Khachatryan A; Banon T; Kapnang R; Kikuchi K; Ren H; Massien C; Vigié L; Larsen S; Sibon I
Cardiovasc Diabetol; 2024 May; 23(1):183. PubMed ID: 38812009
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of acupuncture on cardiovascular complications in patients with diabetes mellitus in Korea: A nationwide retrospective cohort.
Jung H; Won T; Kim GY; Jang J; Yeo S; Lim S
J Integr Med; 2023 Mar; 21(2):176-183. PubMed ID: 36797171
[TBL] [Abstract][Full Text] [Related]
24. Risk of stroke with thiazolidinediones: a ten-year nationwide population-based cohort study.
Lu CJ; Sun Y; Muo CH; Chen RC; Chen PC; Hsu CY
Cerebrovasc Dis; 2013; 36(2):145-51. PubMed ID: 24029780
[TBL] [Abstract][Full Text] [Related]
25. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.
Ou HT; Chang KC; Li CY; Wu JS
Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742
[TBL] [Abstract][Full Text] [Related]
26. Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone.
Graham DJ; Ouellet-Hellstrom R; MaCurdy TE; Ali F; Sholley C; Worrall C; Kelman JA
JAMA; 2010 Jul; 304(4):411-8. PubMed ID: 20584880
[TBL] [Abstract][Full Text] [Related]
27. Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.
Lincoff AM; Wolski K; Nicholls SJ; Nissen SE
JAMA; 2007 Sep; 298(10):1180-8. PubMed ID: 17848652
[TBL] [Abstract][Full Text] [Related]
28. Pioglitazone improves insulin sensitivity among nondiabetic patients with a recent transient ischemic attack or ischemic stroke.
Kernan WN; Inzucchi SE; Viscoli CM; Brass LM; Bravata DM; Shulman GI; McVeety JC; Horwitz RI
Stroke; 2003 Jun; 34(6):1431-6. PubMed ID: 12730556
[TBL] [Abstract][Full Text] [Related]
29. Effects of Statin Intensity and Adherence on the Long-Term Prognosis After Acute Ischemic Stroke.
Kim J; Lee HS; Nam CM; Heo JH
Stroke; 2017 Oct; 48(10):2723-2730. PubMed ID: 28916672
[TBL] [Abstract][Full Text] [Related]
30. Weight change and mortality and cardiovascular outcomes in patients with new-onset diabetes mellitus: a nationwide cohort study.
Kim MK; Han K; Koh ES; Kim ES; Lee MK; Nam GE; Kwon HS
Cardiovasc Diabetol; 2019 Mar; 18(1):36. PubMed ID: 30890169
[TBL] [Abstract][Full Text] [Related]
31. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: rationale and design of the Insulin Resistance Intervention after Stroke Trial.
Viscoli CM; Brass LM; Carolei A; Conwit R; Ford GA; Furie KL; Gorman M; Guarino PD; Inzucchi SE; Lovejoy AM; Parsons MW; Peduzzi PN; Ringleb PA; Schwartz GG; Spence JD; Tanne D; Young LH; Kernan WN;
Am Heart J; 2014 Dec; 168(6):823-9.e6. PubMed ID: 25458644
[TBL] [Abstract][Full Text] [Related]
32. Impact of Metformin on the Severity and Outcomes of Acute Ischemic Stroke in Patients with Type 2 Diabetes Mellitus.
Mima Y; Kuwashiro T; Yasaka M; Tsurusaki Y; Nakamura A; Wakugawa Y; Okada Y
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):436-46. PubMed ID: 26725260
[TBL] [Abstract][Full Text] [Related]
33. Effects of Pioglitazone for Secondary Stroke Prevention in Patients with Impaired Glucose Tolerance and Newly Diagnosed Diabetes: The J-SPIRIT Study.
Tanaka R; Yamashiro K; Okuma Y; Shimura H; Nakamura S; Ueno Y; Tanaka Y; Miyamoto N; Tomizawa Y; Nakahara T; Furukawa Y; Watada H; Kawamori R; Hattori N; Urabe T
J Atheroscler Thromb; 2015; 22(12):1305-16. PubMed ID: 26269002
[TBL] [Abstract][Full Text] [Related]
34. Pioglitazone Prevents Diabetes in Patients With Insulin Resistance and Cerebrovascular Disease.
Inzucchi SE; Viscoli CM; Young LH; Furie KL; Gorman M; Lovejoy AM; Dagogo-Jack S; Ismail-Beigi F; Korytkowski MT; Pratley RE; Schwartz GG; Kernan WN;
Diabetes Care; 2016 Oct; 39(10):1684-92. PubMed ID: 27465265
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance.
Spence JD; Viscoli C; Kernan WN; Young LH; Furie K; DeFronzo R; Abdul-Ghani M; Dandona P; Inzucchi SE
Diabetes Obes Metab; 2022 Jun; 24(6):1150-1158. PubMed ID: 35253334
[TBL] [Abstract][Full Text] [Related]
36. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Dormandy JA; Charbonnel B; Eckland DJ; Erdmann E; Massi-Benedetti M; Moules IK; Skene AM; Tan MH; Lefèbvre PJ; Murray GD; Standl E; Wilcox RG; Wilhelmsen L; Betteridge J; Birkeland K; Golay A; Heine RJ; Korányi L; Laakso M; Mokán M; Norkus A; Pirags V; Podar T; Scheen A; Scherbaum W; Schernthaner G; Schmitz O; Skrha J; Smith U; Taton J;
Lancet; 2005 Oct; 366(9493):1279-89. PubMed ID: 16214598
[TBL] [Abstract][Full Text] [Related]
37. Thiazolidinediones and the risk of incident strokes in patients with type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Filion KB; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):343-50. PubMed ID: 19998318
[TBL] [Abstract][Full Text] [Related]
38. Poststroke glycemic variability increased recurrent cardiovascular events in diabetic patients.
Yoon JE; Sunwoo JS; Kim JS; Roh H; Ahn MY; Woo HY; Lee KB
J Diabetes Complications; 2017 Feb; 31(2):390-394. PubMed ID: 27956053
[TBL] [Abstract][Full Text] [Related]
39. Long-term effects of pioglitazone on first attack of ischemic cerebrovascular disease in older people with type 2 diabetes: A case-control study in Taiwan.
Lai SW; Lin HF; Lin CL; Liao KF
Medicine (Baltimore); 2016 Aug; 95(31):e4455. PubMed ID: 27495077
[TBL] [Abstract][Full Text] [Related]
40. Pioglitazone Therapy and Fractures: Systematic Review and Meta- Analysis.
Pavlova V; Filipova E; Uzunova K; Kalinov K; Vekov T
Endocr Metab Immune Disord Drug Targets; 2018; 18(5):502-507. PubMed ID: 29683100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
